Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 13,274 shares at $20.33 ($270K) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Scheduled sale ($270k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.33 | 6,607 | $134K | 49.8% |
| 2 | $20.33 | 6,607 | $134K | 49.8% |
| 3 | $21.16 | 60 | $1K | 0.5% |
| Total | $20.33 avg | 13,274 | $270K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |